Nectar Lifesciences Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Raman Goyal, was filed 27 Nov 2025.
Nectar Lifesciences Limited: what insiders have been doing
Nectar Lifesciences Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). Between 8 November 2025 and 8 November 2026, 2 insiders published 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of Nectar Lifesciences Limited has been absent for the past year.
Compared with its exchange (1,985 companies, median 4 filings), a count of 2 filings is below the norm. Looking back to 2021, when coverage begins, insiders filed 2 purchases and 1 sale.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -47.0%Entry ₹41.80 · Close at T+365 ₹22.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 8,000,000 sharesEquity SharesSEBI:d5e83770c3abb3ea8a9e9e087ed2b75cece4e290
- 8,000,000 sharesEquity SharesSEBI:b8b1f3792a4cc3e92b8cbffe3d9c50aa69d3245cCanonical exit: 25 Feb 2026 (T+90)
- 99,468,000 shares@ ₹9.2869100.0% of flowEquity SharesSEBI:b5f11ced9ef9218286caeceabe7e4d651d739f34
- 43,622,400 shares@ ₹15.76100.0% of flowEquity SharesSEBI:dc4e5149956d38555a4a1f880d2631b07667ad7f
- 43,622,400 shares@ ₹15.7630.5% of flowEquity SharesSEBI:4223696eb4967a6f4ed6bbf56d29a7243bb9c6dc
- 55,845,600 shares@ ₹15.7630.5% of flowEquity SharesSEBI:e5f0d20f8156c5b07b23dabed59438a5a104ab12
- 400,000 shares@ ₹44.37100.0% of flowEquity SharesSEBI:69bf507ee746191fb677d1410ca5d787f75712e0Canonical exit: 19 Mar 2025 (T+90)
- 99,468,000 shares@ €0.3497100.0% of flowEquity SharesSEBI:2547904c304d5ece7a7c9114d35928642fd7380f
- 55,845,600 shares@ ₹31.0569.5% of flowEquity SharesSEBI:b3ee334b1850baac9a94e85462fb6923f3d07650
- 43,622,400 shares@ ₹31.0586.21% mcap69.5% of flowEquity SharesSEBI:2fa4a5cb93d4674b0c5a178b49772057e0485362
10 of 10 declarations
About Nectar Lifesciences Limited
Nectar Lifesciences Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XBOM market.
